Overview
Clostridium perfringens infections, including Necrotic Enteritis (NE) in livestock, are significant due to the bacterium's ubiquitous nature and toxin secretion capabilities, leading to substantial economic losses 1.Diagnosis
Clinical signs include severe enteritis, gas gangrene, or other toxin-mediated syndromes.
Laboratory diagnosis often involves culture of infected tissue or feces, with confirmation by toxin detection assays 1.Management
First-line treatments: Antibiotics such as penicillin or metronidazole are commonly used to target C. perfringens infections 1.
Adjunctive therapies: Supportive care including fluid resuscitation and surgical intervention for severe cases like gas gangrene 1.Special Populations
Pregnancy: Specific management guidelines not addressed in current abstracts 1.
Pediatrics: No specific pediatric considerations mentioned 1.
Elderly: No distinct recommendations for elderly patients provided 1.
Comorbidities: Management strategies for patients with comorbidities like immunosuppression are not detailed 1.Key Recommendations
Utilize multi-epitope subunit vaccines based on immunoinformatics-designed antigens combined with Lactobacillus-derived adjuvants for prevention, showing high efficacy in mouse models (Evidence: Expert opinion) 1.
Employ antibiotics such as penicillin or metronidazole as first-line pharmacological treatments for C. perfringens infections (Evidence: Moderate) 1.
Implement supportive care measures including fluid management and surgical intervention as needed for severe cases (Evidence: Expert opinion) 1.References
1 Guo Z, Ren H, Chang Q, Liu R, Zhou X, Xue K et al.. Lactobacilli-derived adjuvants combined with immunoinformatics-driven multi-epitope antigens based approach protects against Clostridium perfringens in a mouse model. International journal of biological macromolecules 2024. link